PDEXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30

PRO DEX INC

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 3, 2026

$57.70−0.56 (-0.96%)

Close on Oct 19, 2026

Margins

Share of revenue, fiscal years 2012 to 2026

31.4%−4.3 pts over 5 years

16.8%+4.9 pts over 5 years

17.6%+1.4 pts over 5 years

Compound annual growth to fiscal 2026

Per year	1 year	3 years	5 years	10 years
Revenue	+16.5%	+18.9%	+15.3%	+15.0%
Gross profit	+24.7%	+24.0%	+12.4%	+17.3%
Operating income	+21.5%	+31.1%	+23.5%	+32.0%
Net income	+52.2%	+24.5%	+17.2%	+32.5%
EPS, diluted	+54.3%	+28.3%	+21.3%	+35.3%
Free cash flow	–	–	–	+45.9%

10 fiscal years. Hover a measure to see how it is calculated.

Measure	FY2017	FY2021	FY2026
Return on equity	45.0%	30.7%	32.4%
Return on assets	37.0%	17.3%	20.1%
Current ratio	4.76	3.99	4.10
Debt to equity	0.01	0.60	0.28
Net debt to EBITDA	-1.24×	1.74×	0.35×
Interest coverage	228.1×	12.9×	16.0×
Inventory turnover	4.6×	2.9×	2.4×
Capex to revenue	2.8%	4.7%	0.6%
Diluted shares	4M	4M	3M

Return on equity split into margin, efficiency and leverage

Net margin17.6%

Asset turnover1.14×

Equity multiplier1.61×

Return on equity, FY202632.4%

Fiscal year	Net margin	Asset turnover	Equity multiplier	Return on equity
FY2026	17.6%	1.14×	1.61×	32.4%
FY2025	13.5%	1.17×	1.68×	26.6%
FY2024	4.0%	1.03×	1.67×	6.8%
FY2023	15.3%	0.91×	1.77×	24.8%
FY2022	10.9%	0.94×	1.92×	19.6%
FY2021	16.2%	1.06×	1.78×	30.7%
FY2020	17.5%	1.23×	1.57×	33.9%
FY2019	15.3%	1.20×	1.33×	24.2%
FY2018	7.2%	1.24×	1.17×	10.5%
FY2017	23.2%	1.60×	1.22×	45.0%

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is PDEX.

Revenue growth16.5% · median 24.0%

Gross margin31.4% · median 63.5%

Operating margin16.8% · median -6.1%

Net margin17.6% · median -35.9%

Advertisement
300 × 250